258 related articles for article (PubMed ID: 29194722)
1. The RNA genome of hepatitis E virus robustly triggers an antiviral interferon response.
Wang W; Wang Y; Qu C; Wang S; Zhou J; Cao W; Xu L; Ma B; Hakim MS; Yin Y; Li T; Peppelenbosch MP; Zhao J; Pan Q
Hepatology; 2018 Jun; 67(6):2096-2112. PubMed ID: 29194722
[TBL] [Abstract][Full Text] [Related]
2. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
[TBL] [Abstract][Full Text] [Related]
3. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
[TBL] [Abstract][Full Text] [Related]
4. The U-Rich Untranslated Region of the Hepatitis E Virus Induces Differential Type I and Type III Interferon Responses in a Host Cell-Dependent Manner.
Sooryanarain H; Heffron CL; Meng XJ
mBio; 2020 Jan; 11(1):. PubMed ID: 31937650
[TBL] [Abstract][Full Text] [Related]
5. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.
Haldipur B; Bhukya PL; Arankalle V; Lole K
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540601
[TBL] [Abstract][Full Text] [Related]
6. Suppression of interferon-α signaling by hepatitis E virus.
Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S
Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878
[TBL] [Abstract][Full Text] [Related]
7. Host Innate Immunity against Hepatitis E Virus and Viral Evasion Mechanisms.
Kang S; Myoung J
J Microbiol Biotechnol; 2017 Oct; 27(10):1727-1735. PubMed ID: 29017236
[TBL] [Abstract][Full Text] [Related]
8. Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication.
Wang Y; Wang W; Xu L; Zhou X; Shokrollahi E; Felczak K; van der Laan LJ; Pankiewicz KW; Sprengers D; Raat NJ; Metselaar HJ; Peppelenbosch MP; Pan Q
Antimicrob Agents Chemother; 2016 May; 60(5):2834-48. PubMed ID: 26926637
[TBL] [Abstract][Full Text] [Related]
9. The Capsid Protein of Hepatitis E Virus Inhibits Interferon Induction via Its N-terminal Arginine-Rich Motif.
Lin S; Yang Y; Nan Y; Ma Z; Yang L; Zhang YJ
Viruses; 2019 Nov; 11(11):. PubMed ID: 31717991
[TBL] [Abstract][Full Text] [Related]
10. Advances in Hepatitis E Virus Biology and Pathogenesis.
Lin S; Zhang YJ
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572257
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis E virus persists in the presence of a type III interferon response.
Yin X; Li X; Ambardekar C; Hu Z; Lhomme S; Feng Z
PLoS Pathog; 2017 May; 13(5):e1006417. PubMed ID: 28558073
[TBL] [Abstract][Full Text] [Related]
12. IFN-λ3 as a host immune response in acute hepatitis E virus infection.
Murata K; Kang JH; Nagashima S; Matsui T; Karino Y; Yamamoto Y; Atarashi T; Oohara M; Uebayashi M; Sakata H; Matsubayashi K; Takahashi K; Arai M; Mishiro S; Sugiyama M; Mizokami M; Okamoto H
Cytokine; 2020 Jan; 125():154816. PubMed ID: 31465972
[TBL] [Abstract][Full Text] [Related]
13. Genetic and physicochemical analyses of a novel ferret hepatitis E virus, and clinical signs of infection after birth.
Li TC; Yoshizaki S; Kataoka M; Ami Y; Suzaki Y; Doan YH; Haga K; Ishii K; Takeda N; Wakita T
Infect Genet Evol; 2017 Jul; 51():153-159. PubMed ID: 28347753
[TBL] [Abstract][Full Text] [Related]
14. Progesterone-Mediated Enhancement of Hepatitis E Virus Replication in Human Liver Cells.
Sooryanarain H; Ahmed SA; Meng XJ
mBio; 2021 Jun; 12(3):e0143421. PubMed ID: 34154410
[TBL] [Abstract][Full Text] [Related]
15. Disparity of basal and therapeutically activated interferon signalling in constraining hepatitis E virus infection.
Zhou X; Xu L; Wang W; Watashi K; Wang Y; Sprengers D; de Ruiter PE; van der Laan LJ; Metselaar HJ; Kamar N; Peppelenbosch MP; Pan Q
J Viral Hepat; 2016 Apr; 23(4):294-304. PubMed ID: 26620360
[TBL] [Abstract][Full Text] [Related]
16. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
Sayed IM; Verhoye L; Cocquerel L; Abravanel F; Foquet L; Montpellier C; Debing Y; Farhoudi A; Wychowski C; Dubuisson J; Leroux-Roels G; Neyts J; Izopet J; Michiels T; Meuleman P
Gut; 2017 May; 66(5):920-929. PubMed ID: 27006186
[TBL] [Abstract][Full Text] [Related]
17. The Amino-Terminal Region of Hepatitis E Virus ORF1 Containing a Methyltransferase (Met) and a Papain-Like Cysteine Protease (PCP) Domain Counteracts Type I Interferon Response.
Bagdassarian E; Doceul V; Pellerin M; Demange A; Meyer L; Jouvenet N; Pavio N
Viruses; 2018 Dec; 10(12):. PubMed ID: 30567349
[TBL] [Abstract][Full Text] [Related]
18. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.
Allweiss L; Gass S; Giersch K; Groth A; Kah J; Volz T; Rapp G; Schöbel A; Lohse AW; Polywka S; Pischke S; Herker E; Dandri M; Lütgehetmann M
J Hepatol; 2016 May; 64(5):1033-1040. PubMed ID: 26805671
[TBL] [Abstract][Full Text] [Related]
19. Study of cellular immune response against Hepatitis E virus (HEV).
Prabhu SB; Gupta P; Durgapal H; Rath S; Gupta SD; Acharya SK; Panda SK
J Viral Hepat; 2011 Aug; 18(8):587-94. PubMed ID: 20579277
[TBL] [Abstract][Full Text] [Related]
20. Immunity against hepatitis E virus infection: Implications for therapy and vaccine development.
Hakim MS; Ikram A; Zhou J; Wang W; Peppelenbosch MP; Pan Q
Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29272060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
